Effect of bile acids on butyrate-sensitive and -resistant human colon adenocarcinoma cells

Nutrition and Cancer

Volumn 53, Issue 2, 2005, Pages 208-219

  Pérez Ramos, Pablo ^a   Olmo, Nieves ^a   Turnay, Javier ^a   Lecona, Emilio ^a   González De Buitrago, Gonzalo ^a   Portolés, M Teresa ^a   Lizarbe, M Antonia ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BUTYRIC ACID; CASPASE 3; CHENODEOXYCHOLIC ACID; DEOXYCHOLIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; IC 50; STEREOSPECIFICITY;

ADENOCARCINOMA; APOPTOSIS; BILE ACIDS AND SALTS; BUTYRATES; CASPASE 3; CASPASES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; TIME FACTORS;

EID: 33645916716     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5302_10     Document Type: Article

References (39)

1. Hofmann AF: The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159, 2647-2658, 1999.
2. Powell AA, LaRue JM, Batta AK, and Martinez JD: Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. Biochem J 356, 481-486, 2001.
3. Bernstein H, Bernstein C, Payne CM, Dvorakova K, and Garewal H: Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589, 47-65, 2005.
4. Kishida T, Taguchi F, Tatsuguchi A, Sato J, Fujimori S, et al.: Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects. J Gastroenterol 32, 306-311, 1997.
5. Chaplin MF: Bile acids, fibre and colon cancer: the story unfolds. J R Soc Health 118, 53-61, 1998.
6. Pai R, Tarnawski AS, and Tran T: Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell 15, 2156-2163, 2004.
7. Payne CM, Bernstein H, Bernstein C, and Garewal H: Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol 19, 221-228, 1995.
8. Looby E, Long A, Kelleher D, and Volkov Y: Bile acid deoxycholate induces differential subcellular localisation of the PKC isoenzymes beta 1, epsilon and delta in colonic epithelial cells in a sodium butyrate insensitive manner. Int J Cancer 114, 887-895, 2005.
9. 2t.
10. Dvorakova K, Payne CM, Ramsey L, Bernstein H, Holubec H, et al.: Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am J Gastroenterol 100, 424-431, 2005.
11. Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, et al.: Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 23, 2063-2080, 2002.
12. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, et al.: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103, 137-145, 1999.
13. Peiffer LP, Peters DJ, and McGarrity TJ: Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro. Dig Dis Sci 42, 2234-2240, 1997.
14. Schlottmann K, Wachs F-P, Krieg RC, Kullmann F, Schölmerich J, et al.: Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res 60, 4270-4276, 2000,
15. Milovic V, Teller IC, Faust D, Caspary WF, and Stein J: Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur J Clin Invest 32, 29-34, 2002.
16. Turnay J, Olmo N, Gavilanes JG, Benítez J, and Lizarbe MA: Establishment and characterization of a new human colon-adenocarcinoma cell line: BCS-TC2. Cytotechnology 3, 75-88, 1990.
17. Navarro JM, Olmo N, Turnay J, López-Conejo MT, and Lizarbe MA: Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase of 5′-nucleotidase activity. Eur J Clin Invest 27, 620-628, 1997.
18. Andoh A, Tsujikawa T, and Fujiyama Y: Role of dietary fiber and short-chain fatty acids in the colon. Curr Pharm Des 9, 347-358, 2003.
19. Lopez de Silanes I, Olmo N, Turnay J, González de Buitrago G, Pérez-Ramos P, et al.: Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon adenocarcinoma cells. Cancer Res 64, 4593-4600, 2004.
20. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, et al.: A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 59, 2353-2357, 1999.
21. Turnay J, Olmo N, Jiménez A, Lizarbe MA, and Gavilanes JG: Kinetic study of the cytotoxic effect of α-sarcin, a ribosome inactivating protein from Aspergillus giganteus, on tumour cell lines: protein biosynthesis inhibition and cell binding. Mol Cell Biochem 122, 39-47, 1993.
22. López-Conejo T, Olmo N, Turnay J, Navarro J, and Lizarbe MA: Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line. Int J Cancer 67, 668-675, 1996.
23. López-Conejo MT, Olmo N, Turnay J, López de Silanes I, and Lizarbe MA: Interaction of fibronectin with human colon adenocarcinoma cells: effect on the in vivo tumorigenic capacity. Oncology 62, 371-380, 2002.
24. Olmo N, Turnay J, González de Buitrago G, López de Silanes I, Gavilanes JG, et al.: Cytotoxic mechanism of the ribotoxin alpha-sarcin. Induction of cell death via apoptosis. Eur J Biochem 268, 2113-2123, 2001.
25. Ruiz-Vela A, González de Buitrago G, and Martínez-A C: Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 18, 4988-4998, 1999.
26. Delzenne NM, Calderon PB, Taper HS, and Roberfroid MB: Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies. Toxicol Lett 61, 291-304, 1992.
27. Inokuchi A, Hinoshita E, Iwamoto Y, Kohno K, Kuwano M, et al.: Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. J Biol Chem 276, 46822-46829, 2001.
28. Kramer W: Identification of the bile acid binding proteins in human serum by photoaffinity labelling. Biochim Biophys Acta 1257, 230-238, 1995.
29. Earnshaw WC, Martins LM, and Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68, 383-424, 1999.
30. Glinghammar B, Inoue H, and Rafter JJ: Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Carcinogenesis 23, 839-845, 2002.
31. Velazquez OC, Lederer HM, and Rombeau JL: Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. Adv Exp Med Biol 427, 123-134, 1997.
32. Velazquez OC, Zhou D, Seto RW, Jabbar A, Choi J, et al.: In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-Fos and c-Jun expression. J Parenter Enteral Nutr 20, 243-250, 1996.
33. Paumgartner G and Beuers U: Ursodeoxycholic acid in cholestatic liver disease. Mechanisms of action and therapeutic use revisited. Hepatology 36, 525-531, 2002.
34. Martinez JD, Stratagoules ED, LaRue JM, Powell AA, Gause PR, et al.: Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 31, 111-118, 1998.
35. Haza AI, Glinghammar B, Grandien A, and Rafter J: Effect of colonic luminal components on induction of apoptosis in human colonic cell lines. Nutr Cancer 36, 79-89, 2000.
36. Marchetti MC, Migliorati G, Moraca R, Riccardi C, Nicoletti I, et al.: Possible mechanisms involved in apoptosis of colon tumor cell lines induced by deoxycholic acid, short-chain fatty acids, and their mixtures. Nutr Cancer 28, 74-80, 1997.
37. Chen JS, Faller DV, and Spanjaard RA: Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets 3, 219-236, 2003.
38. Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, et al.: A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 25, 681-692, 2004.
39. McMillan L, Butcher SK, Pongracz J, and Lord JM: Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br J Cancer 88, 748-753, 2003.